October 22, 2024
Onsite Registration Opens in San Diego
October 23, 2024
Early Programs in San Diego
October 24-27, 2024
Annual Meeting
View All#KidneyWk on X 22 hours ago
A study assessed the efficacy of adding sodium zirconium cyclosilicate to allow patients with stage 3-4 DKD to maintain RAASi use. #kidneywk #nepht...
View Post
#KidneyWk on X 1 day ago
The FALCON trial evaluated the safety and efficacy of bardoxolone methyl in patients with autosomal dominant polycystic kidney disease. #nephrology...
View Post
#KidneyWk on X 2 days ago
A substudy of POISE-3 data presented at #KidneyWk sought to find out whether a perioperative hypotension-avoidance strategy changes the risk of pos...
View Post
#KidneyWk on X 3 days ago
RT @Neph_Times: A study examined the efficacy and safety of obinutuzumab to treat patients with focal segmental glomerulosclerosis who were…
View Post
#KidneyWk on X 3 days ago
A study examined the efficacy and safety of obinutuzumab to treat patients with focal segmental glomerulosclerosis who were treatment-resistant or ...
View Post
#KidneyWk on X Tuesday, January 14 @ 10:19 PM
RT @nefrorantes: Our last most presentation regarding Wearable Artificial Kidney #WAK 3.0 at the American Congress of Nephrology in Pennsyl…
View Post
#KidneyWk on X Tuesday, January 14 @ 1:16 PM
RT @nefrorantes: Our last most presentation regarding Wearable Artificial Kidney #WAK 3.0 at the American Congress of Nephrology in Pennsyl…
View Post
#KidneyWk on X Tuesday, January 14 @ 1:06 PM
RT @nefrorantes: Our last most presentation regarding Wearable Artificial Kidney #WAK 3.0 at the American Congress of Nephrology in Pennsyl…
View Post